3650 results for «318»

Filter By

3650 results

Which valve is best for my patient?

21 May 2025 – From EuroPCR 2025

This session guides clinicians in selecting the most appropriate transcatheter aortic valve tailored to individual patient characteristics. Through diverse case discussions, including patients with coronary artery disease, small anatomies, bicuspid valves, and surgical bioprostheses, it elucidates decision-making processes and planning for complex TAVI anatomies.

Which valve is best for my patient?

Current DCB practice: from lesion preparation to follow-up

21 May 2025 – From EuroPCR 2025

Explore current best practices in drug-coated balloon (DCB) angioplasty from lesion preparation to follow-up. This session discusses common indications, management of dissections and complications, and shares practical tips and case examples, equipping clinicians with comprehensive knowledge to optimize DCB use in contemporary PCI.

Current DCB practice: from lesion preparation to follow-up

Acute and late coronary complications post-TAVI

21 May 2025 – From EuroPCR 2025

Gain insights into acute and late coronary complications following TAVI. This session discusses angina post-TAVI, mechanisms of acute severe mitral regurgitation during TAVR, hidden coronary obstructions, sudden hemodynamic collapse, and acute coronary occlusion after balloon aortic valvuloplasty.

Acute and late coronary complications post-TAVI

Atherectomy for CTO-PCI

22 May 2025 – From EuroPCR 2025

Explore atherectomy applications in CTO-PCI with cases demonstrating reverse cart technique, orbital atherectomy in heavily calcified occlusions, and management of atherectomy-induced coronary dissection. Gain practical insights into navigating complex CTO lesions with atherectomy support.

Atherectomy for CTO-PCI

Best clinical CTO cases

19 May 2026 – From EuroPCR 2026

This session presents exemplary clinical cases in chronic total occlusion (CTO) PCI, illustrating advanced procedural strategies and complication management. Cases include retrograde CTO-PCI complicated by catheter-induced dissection, expansion of antegrade CTO PCI limits with hybrid approaches, successful combined antegrade and retrograde hydrodynamic contrast recanalisation, and staged...

Best clinical CTO cases

Innovating heart failure care: from real-time monitoring to mechanical support

18 May 2026 – From EuroPCR 2026

Innovations in heart failure care are transforming patient management, from real-time, non-invasive congestion monitoring to advanced mechanical support systems. This session presents the Anusar congestion assessment tool, early clinical data on the NuPulse intravascular ventricular assist system for ambulatory support, and explores AI-driven voice biomarker technology...

Once you find microvascular disease, what do you actually do?

18 May 2026 – From EuroPCR 2026

Addressing coronary microvascular disease requires a comprehensive understanding of current medical therapies and emerging interventions. This session reviews state-of-the-art pharmacological treatments, elucidates the mechanisms and clinical data surrounding the coronary sinus reducer (CSR), and offers critical discussion on its therapeutic role in microvascular dysfunction.

Re-intervention challenges after first aortic valve replacement

19 May 2026 – From EuroPCR 2026

Addressing the challenges of re-intervention after initial aortic valve replacement, this session highlights advanced valve-in-valve TAVI strategies, including leaflet modification techniques, management of extreme coronary obstruction risks, and complex anatomical considerations such as post-Bentall root anatomy.

Re-intervention challenges after first aortic valve replacement

Selecting PCI devices in specific scenarios

19 May 2026 – From EuroPCR 2026

This session addresses device selection strategies tailored to specific interventional cardiology scenarios. It covers innovative approaches such as coronary laser use in difficult lesions, intravascular imaging-guided treatments for in-stent restenosis, and physiological assessment post-magnesium scaffold resorption, supported by real-world data and emerging machine learning applications.

Bioresorbable devices in clinical practice

19 May 2026 – From EuroPCR 2026

This session examines the evolving role of bioresorbable devices in coronary intervention, showcasing hybrid PCI strategies, novel applications in myocardial bridging, and innovative solutions for complex coronary lesions, including the use of bioadaptors and dual-device techniques.

New evidence in the treatment of calcified lesions

19 May 2026 – From EuroPCR 2026

This session presents the latest evidence on treating calcified coronary lesions, comparing intravascular lithotripsy, cutting balloons, rotational and orbital atherectomy. It includes clinical trial data on efficacy, safety, and impact on coronary microvascular function, providing a robust foundation for evidence-based decision-making in calcified lesion management.

New evidence in the treatment of calcified lesions

Primary PCI in challenging anatomy

19 May 2026 – From EuroPCR 2026

Focusing on primary PCI in challenging coronary anatomies, this session covers intracoronary thrombolysis for ectasia, imaging-guided no-stent strategies in vein graft occlusions, and management of coronary aneurysms presenting with acute coronary syndromes, highlighting tailored interventional approaches.

TAVI procedural complications - Part 1: VSD, valve embolisation, and more

19 May 2026 – From EuroPCR 2026

This session focuses on the complex complications that can arise during TAVI procedures, such as ventricular septal defects, valve embolisation, and other critical events. Through detailed case analyses, it offers strategies for recognition, prevention, and management to improve patient safety and outcomes.

TAVI procedural complications - Part 1: VSD, valve embolisation, and more

Rescue PCI for acute or unusual left main lesions

19 May 2026 – From EuroPCR 2026

This session explores rescue PCI techniques for acute and unusual left main coronary lesions, highlighting complex cases such as left main compression syndrome in pulmonary hypertension, and challenging strategies in acute coronary syndromes with left main occlusion and anatomical variations.

How to prevent and manage complex and complicated LAA closure cases?

19 May 2026 – From EuroPCR 2026

Designed to enhance procedural success in transcatheter left atrial appendage closure, this session addresses identification of complex anatomies, management of intraprocedural challenges, and strategies to prevent and handle complications, illustrated by practical case examples and expert evaluations.

How to prevent and manage complex and complicated LAA closure cases?

FFR- and IVUS-guided PCI of a long and calcified LAD lesion - LIVE case

19 May 2026 – From EuroPCR 2026

A 71‑year‑old man with hypertension and dyslipidemia presented with CCS class II angina and three‑vessel coronary artery disease. Functional assessment included CT‑derived micro‑FFR, angiography‑based FFR, and stress myocardial scintigraphy. The only hemodynamically significant lesion was a long, calcified lesion of the LAD.

Lesion preparation was performed with...

FFR- and IVUS-guided PCI of a long and calcified LAD lesion - LIVE case

How should I treat a patient with a calcified mitral anatomy?

19 May 2026 – From EuroPCR 2026

This session explores the management of patients with calcified mitral anatomy, from advanced imaging assessment to intervention planning. It evaluates the suitability of mitral annular calcification for transcatheter edge-to-edge repair (TEER) and discusses alternative therapeutic options for patients ineligible for TEER.

How should I treat a patient with a calcified mitral anatomy?

Identifying problems and solving complex anatomies during TAVI

19 May 2026 – From EuroPCR 2026

A comprehensive session on managing complex anatomies during Transcatheter Aortic Valve Implantation (TAVI), emphasizing risk markers for peri-operative complications and strategies to address difficult anatomical challenges. Real-world cases illustrate practical approaches and key learnings for handling intricate TAVI scenarios.

Angiography-based physiology in clinical practice

19 May 2026 – From EuroPCR 2026

Investigate the clinical application of angiography-based physiology in coronary artery disease management. This session covers quantitative flow ratio (QFR) guided PCI strategies, risk stratification in chronic coronary syndrome, and prognostic value of angiography-derived indices, offering a wire-free diagnostic approach supported by recent trial data.

Optimal management of primary PCI complications

19 May 2026 – From EuroPCR 2026

This session delves into the optimal management of complications arising during primary PCI. It addresses critical scenarios from initial hesitation and unexpected challenges to confident treatment strategies for vessel complications. Notably, it explores complex cases such as paradoxical embolisation following rescue PCI in STEMI patients, providing...

Didn’t find what you were looking for?